America
New treatment offers hope for treating diabetes, MS
New York, March 5
Researchers have developed a novel and safe treatment for autoimmune diseases including Type-1 diabetes and multiple sclerosis (MS) that arise when the body's immune cells attack itself.
Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.
The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.
In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.
"We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease," said lead author Peng Zhao, from the varsity.
When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.
"We are really taking treatment for the autoimmune disease in a new direction," said Mingnan Chen, Assistant Professor at the varsity.
"To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.
"If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease," Chen said.
In addition, the treatment was also applied to a mouse MS model.
Besides halting the progression of paralysis, the treatment also restored the mice's ability to walk.
In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.
However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells.
Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.
The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.
In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.
"We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease," said lead author Peng Zhao, from the varsity.
When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.
"We are really taking treatment for the autoimmune disease in a new direction," said Mingnan Chen, Assistant Professor at the varsity.
"To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.
"If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease," Chen said.
In addition, the treatment was also applied to a mouse MS model.
Besides halting the progression of paralysis, the treatment also restored the mice's ability to walk.
In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.
However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells.
1 minute ago
S. Korea's overseas financial assets hit record high in Q3: BOK
2 minutes ago
Satya Nadella to visit India from Dec 10–12; to meet top leaders, discuss AI push
3 minutes ago
Apple expands AppleCare+ in India, introduces Theft and Loss coverage with new flexible plans
3 minutes ago
Piyush Goyal meets entrepreneurs, discusses shared vision of Viksit Bharat at 2047
4 minutes ago
Goyal to visit Israel for high-level trade talks, proposed FTA review on agenda
5 minutes ago
'123456' remains India’s most used password for 2nd year: Report
6 minutes ago
Coimbatore to host ‘TN Rising Conclave’ on Nov 25; to bring new investments in TN
13 hours ago
Bihar Elections: India’s Drift Toward One-Party Hegemony (George Abraham)
14 hours ago
Former US Treasury Secretary, Harvard head hit by disclosures in Epstein files
16 hours ago
Manushi Chhillar celebrates 8 Years of her Miss World win
16 hours ago
India-US partnership strong, expanding across strategic and economic sectors: Piyush Goyal
16 hours ago
Cloudflare outage hits X and several digital platforms globally, including India
19 hours ago
After row over childlike sex dolls at Shein, now Hindus upset at Shein for Lord Ganesh blanket
